Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes-Reference-Cited by-同舟云学术

Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes

Published:2020-08-31 Issue:8 Volume:15 Page:e0238016
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Decroo Tom^ORCID,Maug Aung Kya Jai,Hossain Mohamed Anwar,Uwizeye Cécile,Gumusboga Mourad^ORCID,Demeulenaere Tine,Ortuño-Gutiérrez Nimer,de Jong Bouke C.,Van Deun Armand

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. WHO consolidated guidelines on drug-resistant tuberculosis treatment;World Health Organization;World Health Organization Document,2019

2. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data analysis;N Ahmad;Lancet,2018

3. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients;SD Ahuja;PLoS Med,2012

4. Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis;ML Bastos;Clin Infect Dis,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial;BMJ Open;2024-07

2. Evaluation of MeltPro Assay in Identification of Second-Line Injectable Drug Resistance in Multidrug-Resistant Tuberculosis Isolates;Infection and Drug Resistance;2024-05

3. Systematic review of efficacy and safety of shorter regimens for drug-resistant tuberculosis (DR-TB) in children;Clinical Epidemiology and Global Health;2024-05

4. Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study;International Journal of Infectious Diseases;2022-11

5. Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings;JAC-Antimicrobial Resistance;2022-03-18